iHuman

iHuman's flagship product is iHuman Chinese, a gamified app that teaches young children to read and write Chinese characters. Revenue comes primarily from recurring digital subscriptions, supplemented by sales of physical books and learning kits. The company avoids the traditional tutoring model, focusing on self-directed, in-home digital learning.

The 2021 restrictions targeted curriculum-based private tutoring for K-12 students. iHuman publicly stated that its products fall outside this scope because they target pre-school children and focus on self-directed digital edutainment rather than formal tutoring. The company maintained its core operations and NYSE listing through the regulatory shift.

Founder Chi Ming Tsoi exercises control through a dual-class share structure that concentrates voting power with the founder and management, even after the 2020 IPO. This structure is common among Chinese tech companies listed in the US and allows the founding team to execute a long-term product strategy without being overridden by public shareholders.

As of its most recent public filings, iHuman reported over 200 million cumulative registered users worldwide, with approximately 20 million monthly active users. The vast majority of this user base is in mainland China, where the company has built brand recognition among parents of young children.

iHuman's operations are predominantly domestic, but it has pursued international content collaborations. Notably, in 2022 the company announced a partnership with Sanrio to co-develop educational content featuring the Hello Kitty intellectual property, aiming to broaden its content library with globally recognized characters.

iHuman is a publicly traded operating company (NYSE: IH), not a family office. It generates revenue directly through its educational products and services rather than managing a family's financial assets. Its inclusion in certain private-wealth databases likely stems from founder Chi Ming Tsoi's entrepreneurial track record and concentrated ownership.

Key risks include variable US-China regulatory relations affecting the audit dispute and potential delisting for US-listed Chinese firms under the Holding Foreign Companies Accountable Act. Additionally, demographic shifts in China's birth rate could shrink the long-term addressable market for early-childhood education products.